Improving chemotherapeutic efficiency in acute myeloid leukemia treatments by chemically synthesized peptide interfering with CXCR4/CXCL12 axis
2015 · Scientific Reports · 42 citations
https://doi.org/10.1038/srep16228
Y
Yanlian Yang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
107
Papers
2.2K
Citations
26
h-index
55
i10-index
Yanlian Yang is an academic researcher from Peking University. The author has contributed to research in topics: Extracellular vesicles in disease & Alzheimer's disease research and treatments & Chemokine receptors and signaling. The author has an h-index of 26, co-authored 91 publications.
ORCID: 0009-0008-0270-7196Papers by this author
worksAntiamyloidogenic Activity of Aβ42-Binding Peptoid in Modulating Amyloid Oligomerization
2016 · Small · 23 citations
https://doi.org/10.1002/smll.201602857
Molecular recognition of human islet amyloid polypeptide assembly by selective oligomerization of thioflavin T
2020 · Science Advances · 19 citations
https://doi.org/10.1126/sciadv.abc1449
Nanomicelles co-loading CXCR4 antagonist and doxorubicin combat the refractory acute myeloid leukemia
2022 · Pharmacological Research · 19 citations
https://doi.org/10.1016/j.phrs.2022.106503
Enhancement of gold-nanocluster-mediated chemotherapeutic efficiency of cisplatin in lung cancer
2021 · Journal of Materials Chemistry B · 12 citations
https://doi.org/10.1039/d1tb00276g
Structural evolution of the conformational ensembles in peptide fibrillar aggregates
2024 · Materials Today Physics · 6 citations
https://doi.org/10.1016/j.mtphys.2024.101437
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat